Samsung Biologics
207940.KS
#478
Rank
NZ$89.46 B
Marketcap
NZ$1,844
Share price
-1.45%
Change (1 day)
24.95%
Change (1 year)

Market capitalization of Samsung Biologics (207940.KS)

Market cap: NZ$89.46 Billion

As of November 2026 Samsung Biologics has a market cap of NZ$89.46 Billion. This makes Samsung Biologics the world's 478th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Samsung Biologics from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$89.46 B-4.55%
2025NZ$93.72 B16.97%
2024NZ$80.12 B21.29%
2023NZ$66.06 B-8.95%
2022NZ$72.55 B-1.3%
2021NZ$73.51 B5.44%
2020NZ$69.71 B89.52%
2019NZ$36.78 B7.72%
2018NZ$34.15 B5.68%
2017NZ$32.31 B170.06%
2016NZ$11.96 B